Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia
- PMID: 10985259
Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia
Abstract
The neuropathogenesis of HIV-1 infection revolves around the production of secretory factors from immune-activated brain mononuclear phagocytes (MP). MP-secreted chemokines may play several roles in HIV-1 encephalitis (HIVE). These can promote macrophage brain infiltration, blood-brain barrier (BBB) and neuronal dysfunction during HIV-1-associated dementia. We investigate how HIV-1-infected MP regulates the production of chemokines and how they influence HIV-1 neuropathogenesis. We demonstrate that HIV-1-infected and immune-activated MP (for example, microglia) and astrocytes produce beta-chemokines in abundance, as shown in both laboratory assays and within infected brain tissue. HIV-1-infected microglia significantly modulate monocyte migration in a BBB model system and in brains of SCID mice with HIVE. HIV-1-infected MP down-regulate tight junction protein and special polarized transport systems on brain microvascular endothelial cells as shown in human autopsy brain tissue and in SCID mice with HIVE. Chemokines can damage neurons directly. Toxicity caused by binding of stromal-derived factor-1alpha to its receptor on neurons exemplifies such mechanism. In toto, these works underscore the diverse roles of chemokines in HIV-1 neuropathogenesis and lay the foundation for future therapeutic interventions.
Similar articles
-
HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia.J Neurovirol. 2000 May;6 Suppl 1:S14-23. J Neurovirol. 2000. PMID: 10871761 Review.
-
GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.Glia. 2002 Aug;39(2):174-83. doi: 10.1002/glia.10095. Glia. 2002. PMID: 12112368
-
Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.J Leukoc Biol. 2003 Nov;74(5):691-701. doi: 10.1189/jlb.0503205. J Leukoc Biol. 2003. PMID: 14595004 Review.
-
Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection.J Hum Virol. 2000 Nov-Dec;3(6):324-34. J Hum Virol. 2000. PMID: 11100913
-
Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.Cell Mol Biol (Noisy-le-grand). 2002 Mar;48(2):137-50. Cell Mol Biol (Noisy-le-grand). 2002. PMID: 11995633 Review.
Cited by
-
Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection.J Neurovirol. 2015 Aug;21(4):399-414. doi: 10.1007/s13365-015-0328-0. Epub 2015 Mar 7. J Neurovirol. 2015. PMID: 25750071
-
Rosiglitazone suppresses HIV-1 Tat-induced vascular inflammation via Akt signaling.Mol Cell Biochem. 2015 Sep;407(1-2):173-9. doi: 10.1007/s11010-015-2467-2. Epub 2015 Jun 6. Mol Cell Biochem. 2015. PMID: 26048716
-
Ramified feline microglia selects for distinct variants of feline immunodeficiency virus during early central nervous system infection.J Neurovirol. 2003 Aug;9(4):465-76. doi: 10.1080/13550280390218779. J Neurovirol. 2003. PMID: 12907391
-
Large animal models of neurological disorders for gene therapy.ILAR J. 2009;50(2):128-43. doi: 10.1093/ilar.50.2.128. ILAR J. 2009. PMID: 19293458 Free PMC article. Review.
-
Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.Curr Pharm Biotechnol. 2011 Jun;12(6):884-96. doi: 10.2174/138920111795542679. Curr Pharm Biotechnol. 2011. PMID: 21235445 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources